IN.TO
InMed Pharmaceuticals Inc
Price:  
4.19 
CAD
Volume:  
15,950.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IN.TO WACC - Weighted Average Cost of Capital

The WACC of InMed Pharmaceuticals Inc (IN.TO) is 8.7%.

The Cost of Equity of InMed Pharmaceuticals Inc (IN.TO) is 8.75%.
The Cost of Debt of InMed Pharmaceuticals Inc (IN.TO) is 5.00%.

Range Selected
Cost of equity 7.20% - 10.30% 8.75%
Tax rate 26.50% - 26.50% 26.50%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.2% - 10.2% 8.7%
WACC

IN.TO WACC calculation

Category Low High
Long-term bond rate 3.4% 3.9%
Equity market risk premium 4.7% 5.7%
Adjusted beta 0.81 1.03
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.20% 10.30%
Tax rate 26.50% 26.50%
Debt/Equity ratio 0.01 0.01
Cost of debt 5.00% 5.00%
After-tax WACC 7.2% 10.2%
Selected WACC 8.7%